Remdesivir and baricitinib shortened recovery time from COVID-19 – Medical News Today
Posted: January 3, 2021 at 12:53 pm
Written by Jocelyn Solis-Moreira on January 2, 2021 Fact checked by Mary Cooke, Ph.D.
Results from the ACTT-2 trial reveal that baricitinib combined with remdesivir reduced the recovery time of hospitalized COVID-19 patients from 8 to 7 days. The reduced recovery time was even more significant in patients requiring oxygen or ventilation.
As the world rejoiced over the promising results from several COVID-19 vaccine candidates, the United States set a new record of 300,000 coronavirus deaths. This was a stark reminder that some people cannot wait for a vaccine next spring.
The ACTT-2 clinical trial recently investigated the use of both remdesivir and baricitinib, which may help with the recovery of hospitalized COVID-19 patients. The findings now appear in The New England Journal of Medicine.
Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.
One reason that COVID-19 is so hard to treat is that it has numerous effects on the body. These range from lung infections to neurological problems.
Drug repurposing allows for already approved drugs to expedite drug development.
Baricitinib has approval to treat rheumatoid arthritis. However, a June study in the journal EMBO Molecular Medicine showed evidence to suggest that baricitinibs antiviral and anti-inflammatory properties helped reduce the viral load, decrease inflammation, and improve symptoms of COVID-19 in hospitalized patients.
Remdesivir, an antiviral agent that scientists initially designed to treat Ebola, is beneficial as a COVID-19 treatment. A November clinical trial in The New England Journal of Medicine revealed that people who took remdesivir had a reduced recovery time of 10 days (versus 15 days in people who took a placebo).
Currently, remdesivir is Food and Drug Administration (FDA)-approved for COVID-19 patients requiring hospitalization. However, the World Health Organization (WHO) have cautioned against using remdesivir, citing a lack of survival data to support its use for this purpose.
Therefore, researchers for the ACTT-2 trial hypothesized that combining baricitinib and remdesivir would be more effective than using either drug alone.
From May 8, 2020, to July 1, 2020, the clinical trial enrolled 1,033 people worldwide. Although 48% of the participants were white, 51.4% were Hispanic or Latino, 15% were Black, 9.8% were Asian, and 1% were American Indian or Alaska Native.
The diversity in trial recruitment will make the results more applicable for marginalized populations, who have a disproportionally higher risk of COVID-19 development and death.
The researchers randomly assigned a total of 515 patients to the remdesivir and baricitinib group, while 518 patients took remdesivir and a placebo.
They each received remdesivir through an intravenous line, with a 200-milligram (mg) loading dose on day 1 and a 100-mg maintenance dose for days 2 through 10.
Daily, they received 4 mg of baricitinib for 14 days or until they left the hospital. They received the anti-inflammatory drug via two oral tablets or through a nasogastric tube.
Regardless of the group the patients were in, healthcare professionals monitored them all and provided supportive care from day 1 of treatment through day 29.
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status, notably among patients receiving high-flow oxygen or noninvasive mechanical ventilation, write the study authors.
Those who received remdesivir and baricitinib shortened their recovery time by a median of 1 day, compared with those who took remdesivir and a placebo.
Among those who needed high-flow oxygen or noninvasive ventilation, there was a marked difference in recovery times compared with those in the control group. By day 15, the health conditions of the patients who took remdesivir and baricitinib appeared to be improving.
People in the combination treatment group recovered by the 10th day, compared with the 18 days of recovery the scientists observed in the placebo group.
Although more participants would be necessary to measure a real difference in mortality rates, the combination treatment group appeared to have a lower mortality rate than the placebo group. However, more research is needed to confirm this.
The placebo group reported 28 grade 3 or 4 adverse effects, which the investigators confirmed were associated with the treatment, while the combination group reported 25 adverse effects.
Around 5% of all the participants in the trial experienced hyperglycemia, anemia, decreased lymphocyte counts, and acute kidney injury.
Due to the differences in trial design and drug biology, the researchers could not compare their findings to those of the clinical trial that evaluated the corticosteroid dexamethasone.
Dexamethasone has emerged as a leading treatment for severe COVID-19. The New England Journal of Medicine published preliminary results of the RECOVERY clinical trial, which found that dexamethasone reduced the risk of death in severe COVID-19 cases that required treatment with oxygen.
As the authors write:
Only a randomized, double-blind, placebo-controlled, head-to-head comparison of baricitinib plus remdesivir with dexamethasone plus remdesivir will allow the efficacy and safety differences between these two approaches to be fully understood.
Currently, remdesivir and baricitinib hold emergency use authorization from the FDA to treat diagnosed or suspected COVID-19 in hospitalized patients requiring supplemental oxygen, ventilation, or cardiac or respiratory life support.
The researchers say that another clinical trial for baricitinib is underway and may hold more insight into its efficacy when hospitalized patients with COVID-19 take it.
Overall, the drug combination holds promise in treating severe COVID-19. The researchers are also hopeful that this may help COVID-19 treatment become more accessible to the global community.
Our results and the characteristics of baricitinib, including the fact that it is an oral drug with few drug-drug interactions and a good safety profile, lend itself to use in low-to-middle income countries, they write.
For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.
View original post here:
Remdesivir and baricitinib shortened recovery time from COVID-19 - Medical News Today
- Cocke and Fink: Community organizations work best - Roanoke Times - January 3rd, 2021
- 10 Books To Help You Reach Your Potential In The New Year - Patch.com - January 3rd, 2021
- Hoarding workshop - there is HELP available | Missoula, MT - Patch.com - January 3rd, 2021
- Names and faces - Arkansas Online - January 3rd, 2021
- The Boston Heralds Top 20 stories of 2020 - Boston Herald - January 3rd, 2021
- Opinion: There's power in the spoken word, even if no one else hears - BethesdaMagazine.com - January 3rd, 2021
- Finding time for creativity will give you respite from worries - The Guardian - January 3rd, 2021
- New Year 2021: The resolution we all need to make for mental health - The Indian Express - January 3rd, 2021
- Life coach and movie mentor Dawud Gurevitch prescribes patients with films to boost their happiness - The Irish Sun - January 3rd, 2021
- Book Club: 3 books we read to close out 2020 | KSL.com - KSL.com - January 3rd, 2021
- 10 great local foodie products to help soothe Clevelands cold January bluster - cleveland.com - January 3rd, 2021
- 5 Ways to Take Care of Yourself in the Year Ahead - Rewire.org - January 3rd, 2021
- Three ways to help refugees and each other create a healthy path - Buffalo News - January 3rd, 2021
- Healthcare workers have 7 times the risk of severe COVID-19 - Medical News Today - January 3rd, 2021
- What Taunton's leaders have learned from 2020 that they'll carry into 2021 - Taunton Daily Gazette - January 3rd, 2021
- COVID-19 Decision Fatigue: What It Is and How to Deal With It - Healthline - January 3rd, 2021
- Solon author hopes poetry book will inspire others to love themselves - cleveland.com - January 3rd, 2021
- Sac Self-Help Housing Invites the Community to Donate Items to Housewarming for the Unhoused Drive-Thru - The Sacramento Press - November 24th, 2020
- Bluffton Self Helps gives 400 families a Thanksgiving dinner thanks to generous community donations - WJCL News - November 24th, 2020
- Your Mental Health Can Affect How You Save Money - Daily Journal Online - November 24th, 2020
- Fairway's New Self-Checkout Kiosks are the Buzz of the Neighborhood; Some Approve While Others are 'Flummoxed' - westsiderag.com - November 24th, 2020
- Fight the Power: Squash your beef this holiday season - Charleston Post Courier - November 24th, 2020
- Answer Man: How bad is the rent crisis? How can I help? - Citizen Times - November 24th, 2020
- Whats happening Monday in the north valley - Chico Enterprise-Record - November 24th, 2020
- Driving their way to self-reliance - The New Indian Express - November 24th, 2020
- This Constructed Self of Mine: On the Narrative Possibilities of Racial Melancholia - lareviewofbooks - November 24th, 2020
- 10 Habits Of Resilient Employees And How Company Leaders Can Support Them - Forbes - November 24th, 2020
- At Home Learning, Covid-19, and Working from Home: Managing Stress of 2020 and Beyond - Local Profile - November 24th, 2020
- Credit union moves to DeLand | Business | beacononlinenews.com - The West Volusia Beacon - November 24th, 2020
- HarborOne Bank breaks ground at new West Grove Street location - SouthCoastToday.com - November 24th, 2020
- 10 Tips To Find Balance And Thrive In Your Career During The Holidays - Forbes - November 24th, 2020
- What Is Bigorexia? Definition, Symptoms, Coping & More - Healthline - November 24th, 2020
- Why Self-Help and Development Is Crucial for CEO Success - Yahoo Finance - November 24th, 2020
- What to Know About Dating Someone with Depression - Healthline - November 24th, 2020
- COVID holidays inspire behaviors, expectations for life in new year - Williamsport Sun-Gazette - November 24th, 2020
- In a Time of Darkness, This Student Is Helping His Peers Find Their Authentic Selves - UVA Today - November 24th, 2020
- New Line Up of Virtual Classes Aim to Help Parents and Teachers Through the Holidays and Beyond - Signals AZ - November 24th, 2020
- Trial launched to test app that promises digital self-help for youngsters - Yahoo Finance UK - November 5th, 2020
- Off the Shelves November 5 - Greenfield Daily Reporter - November 5th, 2020
- Op-ed: Health care workers literally lose sleep over pandemic. That's bad for patients. - IndyStar - November 5th, 2020
- Global Airport Self-service Markets, 2019-2020 & Forecast to 2025: COVID-19 Impact - Market is Expected to Expand at a CAGR of 0.3% -... - November 5th, 2020
- Self-care is critical this election season - Famuan - November 5th, 2020
- Teaching: Helping Students Make Sense of the Election - The Chronicle of Higher Education - November 5th, 2020
- Feeling stressed? 3 ways to cope with election results - KCRA Sacramento - November 5th, 2020
- Student initiative helps bring attention to food insecurity - OSU - The Lantern - November 5th, 2020
- Digital Transformation Initiatives Post Pandemic to Drive Marginal Growth in the Global Airport Self-service Market, 2025 - GlobeNewswire - November 5th, 2020
- Election Day is now 'Election Week.' Here are 50 ways to get through it - CNN - November 5th, 2020
- Which Purchases Are Worth the Splurge? - Kiplinger's Personal Finance - November 5th, 2020
- 5 things you can do to stay calm, collected and happy this election season - Citizen Times - November 5th, 2020
- New research documents how COVID-19 multiplies stress and trauma for people with disabilities - Vanderbilt University News - November 5th, 2020
- 17 Breathing Videos That Will Help You Relax and Unwind - Self - November 5th, 2020
- Give more help to caregivers who often ignore self-care: Experts - The Straits Times - November 5th, 2020
- Neocase, leader in cloud-based HR Service Management solutions, has been named a Core Challenger in the EMEA market by Fosway. - GlobeNewswire - November 5th, 2020
- UPs Mirzapur goes global, handicrafts made by citys self-help groups to be exhibited in Japan - Newsroompost - November 5th, 2020
- IIT Bombay launches a self- help website to enhance emotional wellbeing of its students The website is supported by the alumni of Class of 1992 -... - November 5th, 2020
- Clinical trial to assess rehabilitation treatment for infants and toddlers after stroke - Newswise - September 29th, 2020
- Exercise plays a key role in addiction recovery, stresses of pandemic - Las Vegas Sun - September 29th, 2020
- Romance Meets The Real World In 'Real Men Knit' - NPR - September 29th, 2020
- Meet the team of Arcadia, the salon bringing style + color to Avondale - Bham Now - September 29th, 2020
- Great British Baking Show is back on Netflix and coming for Nailed It - Polygon - September 29th, 2020
- In support of student media handoffs and the power of personal essays - Poynter - September 29th, 2020
- The different selves of self help - The Michigan Daily - September 19th, 2020
- Ken Norton, The Former US Marine Who Used A Self-Help Book To Beat Ali - The Sportsman - September 19th, 2020
- How to identify and address feelings of anxiety and depression - IU Newsroom - September 19th, 2020
- VDH COVID-19 Update: Spigot turned to help hospitality industry - Vermont Biz - September 19th, 2020
- Perks and Benefits Remote Workers Actually Want - Built In Chicago - September 19th, 2020
- Keep your coffee and other advice from people who paid off thousands in debt - CNBC - September 19th, 2020
- Suicide Prevention Month - Catholic University of America The Tower - September 19th, 2020
- Diabetes self-management telephone class to begin Oct. 7 - The Tribune - Ironton Tribune - September 19th, 2020
- Jay Shetty: How to "Think Like a Monk" | Amanpour and Company - pbssocal.org - September 19th, 2020
- WebMetrix Group On The 21 Podcasts to Expand Your Mind in 2021 - GlobeNewswire - September 19th, 2020
- This Veteran is Helping Fellow Vets Transition to Civilian Life Through Video Gaming - Good News Network - September 19th, 2020
- Coping and Hoping: Mental Health Tips for Trying Times | University of Michigan - Michigan Medicine - September 19th, 2020
- Sound baths | A holistic approach to relaxation and healing | Your Best Life - KCENTV.com - September 19th, 2020
- You Be the CP: Case Studies of Complex MIH Patients - EMSWorld - September 19th, 2020
- First Things First Adapts to COVID-19 Regulations for Class of 2024 - Wesleyan Argus - September 19th, 2020
- Dallas Therapists Share Their Pandemic Advice for Patients - Dallas Observer - September 19th, 2020
- Citizens Financial's Discount Is Shrinking, But It's Still Too Wide Relative To The Opportunity - Seeking Alpha - September 19th, 2020
- Learning In The Age of COVID: From Chaos Comes Opportunity to Build Community - Sacramento Observer - September 19th, 2020
- COVID-19 | Ayurvedic Effective Measures For Self-Care: In The Absence Of COVID-19 Drug, Precautions Should Be Taken! Can We Use Chyawanprash To... - September 19th, 2020